COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc > Next leg up for biotech as the company gets its new name?

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Jul 30, 2024 10:56pm

75 Views

Post# 36155555

RE:Next leg up for biotech as the company gets its new name?

The US FED meeting is tomorrow.
The new name, new symbol, new branding, new website, and then...

@Barchart

Stocks will jump 4 to 5% in the week following the FOMC meeting says Fundstrat's Tom Lee. He says "Buy the Fear."

prophetoffactz wrote:

@paulkrugman

The eagle has soft landed. The New York Fed’s measure of underlying inflation is now just 2.06 percent. The Fed should cut rates now now now.